(Total Views: 833)
Posted On: 01/25/2018 1:15:39 PM
Post# of 102
As per the insider financial article,
Quote:
NPHC secures cash flow selling an already acquired portfolio of OTC pain drugs while financing revolutionary treatments. Shareholders can profit from an already established business model, and also have chances of making significant returns if the FDA approves the new therapies.
(0)
(0)
